Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-15T03:58:52.854Z Has data issue: false hasContentIssue false
  • English
  • Français

Buspirone augmentation of sertraline

Published online by Cambridge University Press:  02 January 2018

D. B. Menkes
D. B. Menkes*
Affiliation:
University of Otago, P.O. Box 913, Dunedin, New Zealand
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Papers
Information
The British Journal of Psychiatry , Volume 166 , Issue 6 , June 1995 , pp. 823 - 824
Copyright
Copyright © Royal College of Psychiatrists, 1995 

References

Barr, L. C., Goodman, W. K., McDougle, C. J., et al (1994) Tryptophan depletion in obsessive-compulsive patients who respond to serotonin uptake inhibitors. Archives of General Psychiatry, 51, 309–317.CrossRefGoogle Scholar
Bergeron, R., Debonnel, G. & DeMontigny, C. (1993) Modification of the N-methyl D-aspartate response by antidepressant sigma receptor ligands. European Journal of Pharmacology, 240, 319–323.CrossRefGoogle ScholarPubMed
Dominguez, R. A. & Mestre, S. M. (1994) Management of treatment-refractory obsessive–compulsive disorder patients. Journal of Clinical Psychiatry, 55 (suppl. 10), 86–92.Google Scholar
Jenike, M. A. & Rauch, S. L. (1994) Managing the patient with treatment-resistant obsessive-compulsive disorder: current strategies. Journal of Clinical Psychiatry, 55 (suppl. 3), 11–17.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.